What treating Ebola means for pandemic influenza

Journal of Public Health Policy
David S Fedson

Abstract

Almost all new treatments being developed for the next influenza pandemic target the virus. During the Ebola crisis in West Africa, patients were treated with an inexpensive generic statin/angiotensin receptor blocker combination that appeared to greatly improve survival. These drugs target the host response, not the virus, and probably reverse endothelial dysfunction. Scientists and health officials have shown little interest in this idea. Yet, during the early months of the next pandemic, vaccines will be unavailable and treatment options will be limited. Physicians should be prepared to undertake clinical trials of widely available generic drugs to determine whether they improve survival in patients with seasonal influenza, other emerging virus diseases, and other forms of acute critical illness. Public health officials should give these studies their strong support. If successful, they will suggest a 'bottom up' approach to patient care that could be implemented worldwide on the first pandemic day.

References

Feb 22, 2001·Annals of Internal Medicine·J P Vandenbroucke
Jul 21, 2005·American Journal of Public Health·Kenneth J Rothman, Sander Greenland
Dec 3, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jeffrey LeviUNKNOWN Working Group on Pandemic Influenza Preparedness
Jun 17, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David S Fedson
Jun 28, 2006·Annals of Internal Medicine·Isaac Starr
Feb 17, 2007·BMJ : British Medical Journal·Paul GlasziouPeter McCulloch
Aug 25, 2007·Journal of Public Health Policy·David S Fedson, Peter Dunnill
Feb 26, 2009·Emerging Infectious Diseases·David S Fedson
Oct 26, 2012·Malaria Research and Treatment·Mariana C SouzaMaria das Graças M O Henriques
Jul 9, 2013·Antiviral Research·David S Fedson
Oct 23, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David S Fedson
Jan 10, 2014·Circulation Journal : Official Journal of the Japanese Circulation Society·Hae-Young LeeKwang Kon Koh
Apr 4, 2014·The New England Journal of Medicine·Harvey V Fineberg
May 3, 2014·International Journal of Molecular Medicine·Parvaneh MehrbodAini Ideris
Aug 28, 2014·The Journal of Infectious Diseases·David S Fedson
Jun 6, 2015·Scientific Reports·Michael G SugiyamaWarren L Lee
Jul 6, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·David S Fedson, Ole Martin Rordam
Sep 18, 2015·Immunity·Giuseppe Danilo NorataFederica M Marelli-Berg
Sep 18, 2015·Frontiers in Immunology·Sergey P MorzunovVincent C Lombardi
Jan 7, 2016·The New England Journal of Medicine·Etienne GignouxIza Ciglenecki
Feb 18, 2016·The New England Journal of Medicine·Timothy M UyekiUNKNOWN Working Group of the U.S.–European Clinical Network on Clinical Management of Ebola Virus Disease Patients in the U.S. and E
May 20, 2016·PLoS Medicine·Lawrence O GostinGabriel M Leung
Jun 9, 2016·Risk Management and Healthcare Policy·Morenike O FolayanBrandon Brown
Jul 30, 2016·Critical Care : the Official Journal of the Critical Care Forum·Aleksandra LeligdowiczRobert A Fowler
Aug 18, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kyle RosenkeEmmie de Wit
Jan 4, 2017·Nature Reviews. Immunology·Miguel P SoaresLuis F Moita
Jan 12, 2017·The Journal of Infectious Diseases·Frederick G HaydenDaniel G Bausch
Jan 19, 2017·The New England Journal of Medicine·John-Arne RøttingenPeter Piot
Mar 14, 2017·Journal of Critical Care·Asgar H RishuUNKNOWN Canadian Critical Care Trials Group
May 4, 2017·The Lancet Infectious Diseases·Amanda RojekJake Dunning
Jun 29, 2017·Lancet·Gerald T Keusch, Keith P W J McAdam
Jun 29, 2017·Lancet·Marie Paule Kieny, Peter Salama
Aug 2, 2017·Current Therapeutic Research, Clinical and Experimental·Hussein SweitiStefan K Lhachimi
Aug 3, 2017·The New England Journal of Medicine·Thomas R Frieden
Aug 11, 2017·Science Translational Medicine·Tim K MackeyTaryn Vian
Sep 19, 2017·New Solutions : a Journal of Environmental and Occupational Health Policy : NS·Melvyn Kopstein

❮ Previous
Next ❯

Citations

Mar 16, 2021·Frontiers in Cardiovascular Medicine·Johanna Hol FosseReidunn Edelmann
Aug 20, 2021·Scientific Reports·Driss Lahlou KitaneJamal Fekkak

❮ Previous
Next ❯

Software Mentioned

ISARIC

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.